PPARA and type 2 diabetes mellitus: Apart from PPAR dual agonist, a pan-PPAR agonist targeting PPAR alpha/delta/gamma has been developed and recently approved for use in patients with T2DM and non-alcoholic steatohepatitis in China [210].